Manage your formulary budget
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Drug patents …
… from Kazakhstan to Kalamazoo
Find generic entry opportunities
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
|Title:||Polymorphs of losartan and the process for the preparation of form II of losartan|
|Abstract:||Polymorphic forms of Losartan (Formula I) ##STR1## and a process for the preparation of Form II of Losartan. Losartan is known to be useful in the treatment of hypertension.|
|Inventor(s):||Campbell, Jr.; Gordon C. (Wilmington, DE), Dwivedi; Anil M. (Newark, DE), Levorse; Dorothy A. (South Amboy, NJ), McCauley; James A. (Bellemeade, NJ), Raghavan; Krishnaswamy S. (Wilmington, DE)|
|Assignee:||Merck & Co., Inc. (Rahway, NJ) E. I. Du Pont de Nemours & Company (Wilmington, DE) The DuPont Merck Pharmaceutical Company (Wilmington, DE)|
Patent Claim Types:|
see list of patent claims
|Patent Number||Expiration Date|
|5,608,075||March 04, 2009|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.